Mireya Paulina Velasquez

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
T cells expressing chimeric antigen receptors (CARs) or the infusion of bispecific T-cell engagers (BITEs) have shown antitumor activity in humans for CD19-positive malignancies. While BITEs redirect the large reservoir of resident T cells to tumors, CAR T cells rely on significant in vivo expansion to exert antitumor activity. We have shown that it is(More)
  • 1